We are live on ! Find out more
SCP

Shorepoint Capital Partners Portfolio holdings

AUM $503M
This Fund
S&P 500
This Quarter Est. Return
+6.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
+$6.59M
Cap. Flow
-$4.83M
Cap. Flow %
-2.58%
Top 10 Hldgs %
32.6%
Holding
82
New
6
Increased
33
Reduced
34
Closed
5

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.95M
2
ABT icon
Abbott
ABT
+$1.71M
3
JPM icon
JPMorgan Chase
JPM
+$922K
4
PNC icon
PNC Financial Services
PNC
+$868K
5
PFE icon
Pfizer
PFE
+$740K

Sector Composition

Rank Sector Weight
1 Healthcare 17.6%
2 Technology 13.02%
3 Financials 11.46%
4 Industrials 8.56%
5 Consumer Staples 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBCT
76
DELISTED
People's United Financial Inc
PBCT
$179K 0.1%
+10,000
New +$161K
NLY icon
77
Annaly Capital Management
NLY
$17.2B
$161K 0.09%
+4,688
New +$159K
BABA icon
78
Alibaba
BABA
$305B
-2,952
Closed -$687K
KMB icon
79
Kimberly-Clark
KMB
$35.7B
-1,895
Closed -$256K
PFE icon
80
Pfizer
PFE
$143B
-20,108
Closed -$740K
PSF icon
81
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
-8,600
Closed -$242K
WEC icon
82
WEC Energy
WEC
$35.6B
-4,465
Closed -$411K

Similar funds

Shorepoint Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Shorepoint Capital Partners held 82 positions worth $187M, up 3.7% from $180M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Shorepoint Capital Partners's Q1 2021 filing shows 6 new, 33 increased, 34 reduced and 5 closed positions. Its largest new stake was American Tower: 3,421 shares worth $818K. The largest sale was AbbVie, an estimated $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Shorepoint Capital Partners's largest Q1 2021 buy was American Tower: 3,421 shares worth $818K.
  • Shorepoint Capital Partners added most to JPMorgan Ultra-Short Municipal Income ETF in Q1 2021, an estimated $3.06M increase.
  • Shorepoint Capital Partners's biggest Q1 2021 reduction was AbbVie, cutting an estimated $2.95M.
  • Shorepoint Capital Partners fully exited Pfizer in Q1 2021, selling an estimated $740K.
  • Shorepoint Capital Partners's ten largest holdings make up 33% of its $187M portfolio in Q1 2021.
  • Shorepoint Capital Partners opened 6 new positions and closed 5 in Q1 2021.
  • Shorepoint Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $187M.

Based on Shorepoint Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.